Common oral medications used in type 2 diabetes patients have recently undergone studies. Studies from Wake Forest University School of Medicine and University of East Angela have concluded that thiazolidinediones (TDZs) used by the elderly and post menopausal women over a course of a year have now doubled their chances at fractures.
Women aged around 70 years old with type 2 diabetes who have taken this medication for a year or more, one additional fracture would occur among every 21 women. Those women who are around 56 years old and have taken TDZs for a year or more resulted in one additional fracture for every 55 women. The concern is that the agents in TDZs are doubling the risk for those that are already at a higher risk before the therapy.
Thiazolidinediones or TDZs are medications to control diabetes by lowering your blood sugar levels. Common drugs that are widely prescribed that fall into the thiazolidinedione drug family are Rosiglitazone also called Avandia TM made by GlaxoSmithKline.
Read more
